What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary areas of investigation include Internal medicine, Surgery, Pancreatic cancer, Oncology and Chemotherapy.
Internal medicine and Gastroenterology are commonly linked in his work.
The study incorporates disciplines such as Neoadjuvant therapy and Pancreatic disease in addition to Surgery.
His research integrates issues of Hepatitis C, Pancreas, HBsAg, Radiology and Gemcitabine in his study of Pancreatic cancer.
His Oncology research incorporates elements of Clinical trial, Bioinformatics, Trastuzumab, Survival rate and General surgery.
His biological study deals with issues like Metastasis, which deal with fields such as Hypertonic saline, Complication and IDH1.
His most cited work include:
- Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group (3088 citations)
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer (905 citations)
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy (600 citations)
What are the main themes of his work throughout his whole career to date?
Robert A. Wolff mainly focuses on Internal medicine, Oncology, Pancreatic cancer, Surgery and Cancer.
His Internal medicine study deals with Gastroenterology intersecting with Ampulla of Vater and Carcinoma.
His study looks at the relationship between Oncology and topics such as Oxaliplatin, which overlap with Irinotecan.
His studies examine the connections between Pancreatic cancer and genetics, as well as such issues in Neoadjuvant therapy, with regards to Pancreaticoduodenectomy.
In general Surgery study, his work on Radiation therapy, Fluorouracil and Retrospective cohort study often relates to the realm of In patient, thereby connecting several areas of interest.
His Adenocarcinoma research is multidisciplinary, incorporating perspectives in Surgical oncology and Pancreas.
He most often published in these fields:
- Internal medicine (66.99%)
- Oncology (49.71%)
- Pancreatic cancer (32.05%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (66.99%)
- Oncology (49.71%)
- Pancreatic cancer (32.05%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Oncology, Pancreatic cancer, Cancer and Colorectal cancer.
Many of his studies on Internal medicine apply to Gastroenterology as well.
His Oncology study also includes fields such as
- Hazard ratio, which have a strong connection to Univariate analysis,
- Carcinoma which connect with Pancreatectomy.
His Pancreatic cancer research is multidisciplinary, incorporating elements of Neoadjuvant therapy, Chemotherapy, FOLFIRINOX and Radiation therapy, Radiology.
His research in Cancer intersects with topics in Germline and General surgery.
His Colorectal cancer research includes themes of Retrospective cohort study, Bioinformatics and Adenocarcinoma.
Between 2016 and 2021, his most popular works were:
- Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology (453 citations)
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. (236 citations)
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. (156 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Robert A. Wolff mainly focuses on Internal medicine, Oncology, Pancreatic cancer, Cancer and Gastroenterology.
His Internal medicine and Colorectal cancer, Adenocarcinoma, Retrospective cohort study, Neoadjuvant therapy and Gemcitabine investigations all form part of his Internal medicine research activities.
His work carried out in the field of Oncology brings together such families of science as Survival rate, Mutation, Carcinoma, Metastasis and Hazard ratio.
Robert A. Wolff has included themes like Chemotherapy, Pancreatectomy, Pancreas, KRAS and Radiation therapy in his Pancreatic cancer study.
Robert A. Wolff has researched Cancer in several fields, including Surgery, Germline, Intensive care medicine, Public health and Risk of infection.
His Surgery research focuses on subjects like Anal cancer, which are linked to Clinical endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
